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Monday, February 22, 2010 357acTnI63-193 found following severe ischemic/reperfusion affects cardiac function
predominantly via decreased myofilament Ca2þ-sensitivity. Our results may
benefit rational drug development aimed to prevent ischemic/reperfusion injury
in patients.
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Muscle contraction is regulated by the troponin complex which is a heterotrimer
protein consisting of a Ca2þ binding subunit (TnC), an inhibitory subunit (TnI)
and a Tropomyosin binding subunit (TnT). Calcium binding to TnC (‘ON’
state) initiates a series of structural changes in the thin filament proteins leading
to muscle contraction. In the low Ca2þ ‘OFF’ state, the TnI subunit induces
muscle inhibition through its two actin binding domains (residues 133-148
and 166-210). Another region of TnI termed the ‘switch peptide’ (residues
150-161) is essential for a complete relieve of muscle inhibition in the ON state.
The position of the switch peptide is vital since it affects the whereabouts of
both TnI actin binding domains. In theþCa2þ cardiac Tn core crystal structure,
the switch peptide is depicted to be close to the N-lobe of TnC (Takeda et al.,
Nature, 2003) but no or limited knowledge is known about its position in the
absence of Ca2þ. We studied the proximity of the switch peptide to two do-
mains within Tn in both the ‘ON’ and ‘OFF’ states. Two intermolecular dis-
tances from each end of the switch peptide back to the N-lobe of TnC
(TnI152/TnC35, TnI152/TnC84, TnI160/TnC55) and one intramolecular dis-
tance (TnI129/TnI160) within TnI were measured with Conventional Electron
Paramagnetic Resonance (cw) and Double Electron Electron Resonance
(DEER) methods. In the ‘ON’ state, both the intramolecular and intermolecular
distances were less than 2.5nm with narrow distance distributions indicative of
restricted movement. Upon removal of Ca2þ, distances increased considerably
(TnI129/160 to 5nm and TnI151/TnC35 to 3.3nm) with an accompanying in-
crease in the distance distributions suggesting a more flexible, non-bound,
switch peptide.
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Ca2þ regulation of cardiac muscle contraction is dependent upon regulation by
tropomyosin (Tm) and troponin (Tn); the extreme C-terminus of the inhibitory
subunit of Troponin (cTnI) binds to actin at low [Ca2þ] and is presumed to hold
Tm in a closed position preventing actomyosin interaction. cTnI’s C terminus
(‘‘mobile domain’’ (MD)) is the site of several human mutations that lead to
familial hypertrophic cardiomyopathy (FHC), therefore it is of interest to clar-
ify the specific function and importance of this domain in cardiac muscle con-
traction. We have demonstrated that even in the absence of Tm, Tn is able to
enhance thin filament sliding speed and heavy meromyosin ATPase activity.
To explore the possibility that theMDplays a role in enhancement of myosin ac-
tivity in cardiac muscle, we have utilized an all-cardiac protein (porcine cardiac
actin andmyosin, recombinant human cardiac Tm-Tn) In VitroMotility assay to
detect alterations in Ca2þ regulation of cardiac actomyosin interaction in the
presence of two specific human recombinant cTn MD structural mutants.
‘‘K164D’’ is truncated after cTnIK164and ‘‘LINK2c2’’ has an inserted8-amino
acid linker before cTnI K164. At pCa5, K164D showed no significant difference
from WT in filament sliding speed at most Tn-Tm concentrations tested, while
sliding speed with LINK 2c2 was significantly slower than WT. Conversely,
at pCa9, K164D was unable to stop actomyosin interaction, with sliding speeds
significantly faster than WT; LINK 2c2 regulated the same as WT at pCa9 for
most concentrations tested. Our in vitro cardiac muscle experimental data sug-
gest that (1) the MD of TnI is a key player in Ca2þ regulation of cardiac muscle
contraction, and (2) the C-terminalMobileDomain of cTnI is not responsible for
observed functional enhancement of myosin at saturating [Ca2þ].
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Troponin I plays an essential role in the regulation of cardiac muscle contrac-
tion. Together with troponin C and T, troponin I induces Ca2þ dependent co-
operative transitions of thin filaments between a blocked, a closed and an
open state. 29 mutations were found in cardiac troponin I in families withhypertrophic cardiomyopathy. Although unknown, the mechanism of molecu-
lar dysfunction is likely to involve an aberrant thin filament responsiveness to
changes in intracellular level of Ca2þ. Our hypothesis is that these mutations
modify important parameters in the cooperative-allosteric transitions of thin fil-
aments. Here we aimed at using transient kinetics to assess the effect of hyper-
trophic cardiomyopathy TnI mutations (Q130R, R145G, and A157V) on the
rate and equilibria of thin filament switching between the blocked, closed
and open states. We found that TnIQ130R and TnIA157V did not affect the
equilibrium constant between the blocked and the closed states (KB). In con-
trast TnIR145G substantially increased KB in the absence of Ca
2þ. An increase
in KB is likely to lead to incomplete relaxation. We also investigated the effect
of these mutations on the cooperative behaviour of thin filaments. TnIQ130R
and A157V did not affect the size of the cooperative unit n while TnIR145G
decrease n value to less than 7. Calcium binding to thin filaments was moni-
tored by change in the fluorescence of IAANS-TnCC84S. Thin filaments recon-
stituted with TnI mutations showed a change in calcium affinity and the rate of
Ca2þ dissociation. These findings suggest that mutations in different regions of
troponin I are likely to have different biochemical effect highlighting the
unique molecular mechanism for each of these mutations.
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Cardiac TnI (cTnI) has a unique N-terminal extension containing the PKA
phosphorylation sites, and its removal by restricted proteolysis in cardiac adap-
tations to hemodynamic stress and b-adrenergic deficiency provides a func-
tional compensation via improving myocardial relaxation (Barbato et al.,
JBC 2005; Feng et al., JBC 2008). By transgenic expression of N-terminal trun-
cated cTnI (cTnI-ND) in the cardiac muscle of cTnI knockout mice, we exam-
ined the function of hearts containing purely cTnI-ND. Working hearts from
the double transgenic mice showed no hypertrophy and normal baseline func-
tion as compared with the wild type controls, confirming the non-destructive
nature of cTnI-ND. When preload was raised to examine the Frank-Starling re-
sponse, left ventricular relaxation velocity was better maintained in cTnI-ND
hearts than that in wild type controls. The effect of cTnI-ND on enhancing re-
laxation resulted in lower left ventricular end diastolic pressure and maintained
left ventricular contractile velocity and end systolic pressure, especially at high
preloads. The overall outcome was larger stroke volumes from cTnI-ND hearts
at increased preloads than the responses of wild type hearts. The enhanced
range and extent of positive response of cTnI-ND hearts to preload demon-
strates that the removal of cTnI N-terminal extension by restricted proteolysis
provides a novel mechanism to maximize the Frank-Starling effect in cardiac
adaptation against hemodynamic and inotropic stresses.
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Mutations in cardiac troponin, a protein complex that regulates muscle contrac-
tion, have been shown to be linked to cardiomyopathies, which commonly lead
to chest pains, myocardial infarction, or sudden cardiac death. The troponin
complex consists of three proteins: Troponin T, Troponin I (TnI), and Troponin
C (TnC). In recent clinical studies, two novel mutations in cardiac TnI were dis-
covered co-segregated with cardiomyopathy, but their specific functional ef-
fects remain unknown. These mutations are the first frameshift mutations in
cTnI known to be linked to restrictive cardiomyopathy (RCM). The deletion
of two adenines at codon 177 (Delbp529AA) in cardiac TnI, was discovered
in a six year old female RCM patient. The second cTnI mutation included in
this investigation was the result of a deleted guanine in codon 168 which caused
a frame shift and premature stop codon at 176 (DelG502). cTnI DelG502 was
associated with sudden cardiac death. It was found during column purification
that the 34 residue truncation of cTnI removed or greatly decreased its binding
affinity for TnC. However, the Delbp529AA mutant protein, containing 32 al-
ternate C-terminal residues, was successfully purified and formed a functional
troponin complex. Actomyosin ATPase assays demonstrated similar maximal
ATPase activity for complexes containing TNNI3 Delbp529AA compared to
wild type complexes. cTnI Delbp529AA showed increased calcium sensitivity
of ATPase and less inhibitory function compared to wild-type cTnI. Calpain
